Mazor Robotics, Israeli developer of surgical robots and complementary products for spine surgery, signed an agreement with Cicel Science & Technology to distribute its Renaissance system in China. As part of the agreement, Cicel is committed to purchase three Renaissance systems for surgical guidance and will use these systems to pursue regulatory clearance from the State Food and Drug Administration (SFDA) in China. View and share
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
UK Adopts Israeli Counter-Drone Technology
April 25, 2024
Top Tel Aviv Hospital Using AI In Neurological Therapy
April 18, 2024
Facebook comments